REPRESENTING THE PROFESSION THAT IMPACTS INDIVIDUAL LIVES AND COMMUNITIES
With
Michelle Oliver,
Chief Occupational Therapist
Occupational Therapy Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Adelaide | November 2025
Michelle Oliver is a highly experienced Occupational Therapist with nearly two decades of leadership and clinical expertise across the mental health, homelessness, and disability sectors. She holds a Master of Occupational Therapy from the University of South Australia and is a registered practitioner with AHPRA.
As the Chief Occupational Therapist at Occupational Therapy Australia (OTA), she leads national strategies to advance clinical excellence, drive workforce development, and champion sector-wide advocacy. Her leadership is crucial in shaping OTA’s influence within the health and disability systems.
Prior to her current role, Michelle served as the Principal Occupational Therapist at the Northern Adelaide Local Health Network, gaining a deep understanding of complex care environments. She is a recipient of a SA Health award for her commitment to consumer, carer, and community participation, and is a public advocate for evidence-based practice and high-quality care.
Source: Supplied
-
Analogy of the system, rather than the ED front door
“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
